Did you know the literature describing the cross-reactivity between cephalosporins and penicillins is 30-40 years old? It sort of takes the "modern" out of "modern medicine."
At any rate, this is a literature review that aims to update the classical
teaching that cross-reactivity between cephalosporins and PCN is ~10%. They
identified 406 articles on the topic and distilled it down to 27 respectable
articles for inclusion in summary. They rate the quality of the articles, and,
unfortunately, find only a few good or outstanding articles and a preponderance
of adequate evidence.
But, essentially, what they find is the cross-reactivity boils down to the
presence of a shared R1 side chain present on first-generation and some
second-generation cephalosporins.
Specific first-generation cephalosporins,
such as cefadroxil (Duracef), were seen to have up to 28% cross-reactivity in
some series, though the typical rate was lower, down to 0.11% with cefazolin
(Ancef).
The largest meta-analyses estimated the true cross-reactivity at ~1%
rather than 10%, with most of these occurring with first-generation
cephalosporins.
In summary - 3rd-generation and greater cephalosporins with disimilar R1
side chains can probably be used in appropriate clinical situations despite a
PCN allergy without incidence of allergy greater than in those patients who do
not have a documented PCN allergy.
The use of cephalosporins in penicillin-allergic patients: A literature review."
Comments
Post a Comment